<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039648</url>
  </required_header>
  <id_info>
    <org_study_id>NRW 300262502</org_study_id>
    <nct_id>NCT02039648</nct_id>
  </id_info>
  <brief_title>The Influence of Rumex Acetosa L on the Intraoral Colonization With Porphyromonas Gingivalis</brief_title>
  <acronym>RPG-I</acronym>
  <official_title>Proanthocyanidin- Enriched Extract From Rumex Acetosa L. as a Prophylactic Agent Against Intraoral Colonization With Porphyromonas Gingivalis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontitis is a biofilm depended oral infection. It leads to inflammatory destruction of
      periodontal tissues and if left untreated to tooth loss. Porphyromonas gingivalis (P.g.) is
      one of the major pathogens associated with the onset and progression of periodontitis.
      Previous in vitro studies have shown that a proanthocyanidin-enriched extract from Rumex
      acetosa L. inhibits the adhesion of P.g. and acts in a cytoprotective manner. Since the the
      bacterial adhesion to oral mucosa cells is a pivotal step for the P.g. mediated tissue
      destruction, its inhibition may be helpful in preventing the colonization with P.g. or its
      eradication in P.g. infected patients. Therefore, the aim of this controlled, randomized and
      double blinded study was to analyze the effects of a Proanthocyanidin-enriched extract from
      Rumex acetosa L. on the intraoral colonization with Porphyromonas gingivalis in individuals
      harboring P.g. intramurally.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During screening phase plaque samples of healthy individuals were tested via polymerase chain
      reaction for the prevalence of P.g..

      At baseline those identified P.g. positive participants received a supragingival debridement
      (professional tooth cleaning) and were randomly assigned to the test- or control-group.
      Afterwards the study participants are instructed to rinse 3 times per day with 10 ml of
      either Rumex acetosa L. extract mouth rinse or the placebo mouth rinse for 7 days in addition
      to their oral hygiene procedures. Plaque samples were taken at different visits (screening,
      baseline, 2, 4, 7 and 14 days after baseline) and P.g. was identified and quantified by
      real-time polymerase chain reaction (qrt-PCR). Also the relative quantity of eight other oral
      pathogenic microorganisms (Aggregatibacter actinomycetemcomitans, Treponema denticola,
      Tannerella forsythia, Prevotella nigrescens, Prevotella intermedia, Eikenella corrodens,
      Streptococcus mutans and Candida albicans) and four commensal bacteria (Streptococcus
      sanguinis, Streptococcus mitis, Veillonella parvula and Actinomyces viscosus) was determined
      over the whole study period by qrt-PCR. Additionally clinical parameters, i.e. the Approximal
      Plaque Index (API) and the modified Sulcular Bleeding Index (SBI) were recorded at baseline,
      7 and 14 days. For identifying any dysplastic changes and mutations as a potential reaction
      to the tested mouthwash solutions brushing biopsies of the oral mucosa were taken at baseline
      and day 7 and were histologically examined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of the intraoral prevalence of Porphyromonas gingivalis</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of the Approximal Plaque Index</measure>
    <time_frame>change from baseline to 7 and 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of the Sulcular Bleeding Index</measure>
    <time_frame>change from baseline to 7 and 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of the cytopathological appearance of the mucosal tissue</measure>
    <time_frame>change from baseline to 7 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Aggregatibacter actinomycetemcomitans</measure>
    <time_frame>change from baseline to 2, 4,7, and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Treponema denticola</measure>
    <time_frame>change from baseline to 2, 4, 7, and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Tannerella forsythia</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Prevotella intermedia</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Prevotella nigrescens</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Eikenella corrodens</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Streptococcus mutans</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Candida albicans</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Streptococcus sanguinis</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Streptococcus mitis</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Veillonella parvula</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>change of the intraoral prevalence of Actinomyces viscosus</measure>
    <time_frame>change from baseline to 2, 4, 7 and 14 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Rumex acetosa L. extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rumex acetosa L. extract mouthrinse, 10 ml, tid, 3 min, 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo mouthrinse, 10 ml, tid, 3 min, 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rumex acetosa L. extract</intervention_name>
    <arm_group_label>Rumex acetosa L. extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  generally healthy

          -  periodontally healthy with Periodontal Screening Index ≤ 2

        Exclusion Criteria:

          -  antibiotic therapy within the previous 6 months

          -  allergies against mouthrinse components

          -  pregnancy or lactation

          -  soft tissue lesions (e.g. lichen planus, leukoplakia)

          -  history of periodontal disease and/ or PSI ≥ 3 or more

          -  any topical or systemical medication, that potentially influence any immunological
             parameters

          -  any systemic disease or medical condition (e.g. diabetes or immunological disorders),
             that potentially influence the immune response or compromise the study results

          -  any systemic conditions, that require an antibiotic coverage for routine dental
             procedures (e.g. endocarditis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Beikler, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich-Heine-University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department od Operative Dentistry, Periodontics and Endodontics</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2014</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2014</study_first_posted>
  <last_update_submitted>January 16, 2014</last_update_submitted>
  <last_update_submitted_qc>January 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Periodontitis</keyword>
  <keyword>Porphyromonas gingivalis</keyword>
  <keyword>Rumex acetosa L.</keyword>
  <keyword>Proanthocyanidins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proanthocyanidin</mesh_term>
    <mesh_term>Procyanidin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

